Henry Schein, Inc. HSIC
- Market cap
- $9.5B
- P/E
- 25.0×
Follow HSIC
Henry Schein, Inc. (HSIC) Return on invested capital
Henry Schein, Inc.'s return on invested capital over the twelve months to 30 June 2026 was 6.97%, up 0.3 percentage points from fiscal 2025 (6.71%). Over the past ten years it has ranged from 6.19% (fiscal 2023) to 13.9% (fiscal 2015); the current reading is higher than 27% of that period. That is above the Medical Distribution industry median of 0.00% and above the Healthcare sector median of 0.00%.
Return on invested capital, annual
Annual
| Period | Return on invested capital | Change (points) |
|---|---|---|
| FY2025 | 6.71% | 0.01 |
| FY2024 | 6.70% | 0.51 |
| FY2023 | 6.19% | (3.10) |
| FY2022 | 9.29% | (1.88) |
| FY2021 | 11.2% | 3.19 |
| FY2020 | 7.98% | (2.57) |
| FY2019 | 10.6% | 2.16 |
| FY2018 | 8.39% | (3.32) |
| FY2017 | 11.7% | (1.99) |
| FY2016 | 13.7% | (0.22) |
Against its own ten years
Return on invested capital against peers
| Company | Return on invested capital |
|---|---|
| CAH Cardinal Health, Inc. compare | 125.1% |
| MCK McKesson Corporation compare | 70.5% |
| COR Cencora, Inc. compare | 15.7% |
| HSIC Henry Schein, Inc. | 6.97% |
| ACH Accendra Health, Inc. compare | 1.58% |
| YI 111, Inc. Sponsored ADR compare | 0.00% |
| AHG Akso Health Group Sponsored ADR compare | 0.00% |
| COSM Cosmos Health Inc. compare | −38.2% |
| FOCL FocalTherics compare | −110.8% |
| Medical Distribution industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Return on invested capital is
Return on Invested Capital shows how much after-tax operating profit a company earns on the money its lenders and shareholders have put in.
TTM: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) (latest quarter) + Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter) − Cash & Short Term Investments (latest quarter)); Annual: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) + Long Term Debt (Total) + Current Part of Debt − Cash & Short Term Investments)
More on HSIC
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement